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Mitochondria present two key roles on cellular functioning: (i) cell metabolism, being the main cellular source of energy
and (ii) modulation of cell death, by mitochondrial membrane permeabilization. Carbon monoxide (CO) is an endogenously
produced gaseoustransmitter, which presents several biological functions and is involved in maintaining cell homeostasis and
cytoprotection.Herein,mitochondrionisapproachedasthemaincellulartargetofcarbonmonoxide(CO).Inthispaper,twomain
perspectives concerning CO modulation of mitochondrial functioning are evaluated. First, the role of CO on cellular metabolism,
in particular oxidative phosphorylation, is discussed, namely, on: cytochrome c oxidase activity, mitochondrial respiration, oxygen
consumption, mitochondrial biogenesis, and general cellular energetic status. Second, the mitochondrial pathways involved in cell
death inhibition by CO are assessed, in particular the control of mitochondrial membrane permeabilization.
1.Introduction
Carbon monoxide (CO) is a colorless and odorless small
molecule, widely known as a lethal gas and as a toxic air pol-
lutant. CO toxicity was disclosed in 1912 by Douglas [1]; its
high aﬃnity for haemglobin, forming carboxyhaemglobin,
compromises oxygen delivery in tissues and subsequently
causes lethality. Several decades later, CO was found as an
endogenous generated gas in humans [2, 3]. However, only
in the late sixties, haem oxygenase (HO) was characterized as
the enzyme responsible for haem cleavage, with the release of
CO, free iron (Fe2+) and biliverdin [4, 5].
There are two genetically distinct isozymes for HO: an
inducible form haem-oxygenase-1 (HO-1) and a consti-
tutively expressed form haem oxygenase-2 (HO-2). HO-1
occurs mainly in spleen, liver or bone marrow, and tissues
that degrade senescent red blood cells; under conditions of
haemolysis its activity dramatically increases. Higher levels
of HO-2 occur mainly in testes and central nervous system
[6]. Increase expression of HO-1 is associated with biological
responsestoseveralsourcesofstress,namely,oxidativestress,
hypoxia, hyperoxia, misfolded protein response, hyperther-
mia, tumour promoter, ultraviolet radiation, and so forth.
Concomitant with the increasing importance of HO activity
in biological systems, CO is largely recognized as a home-
ostatic and cytoprotective molecule [7, 8]. Stimulation of
endogenously generated CO and/or low doses of applied CO
have shown to exert remarkable beneﬁcial biological eﬀects
in many tissues: anti-inﬂammatory, antiapoptotic, antipro-
liferative and antiatherogenic. Three main areas of poten-
tial therapeutic applications have been extensively studied:
cardiovascular diseases, inﬂammatory disorders, and organ
transplantation [7], including the creation of several patents
[9]. In the moment there are two clinical trials phase II
on CO gas inhalation-based therapy: for treating patients
with intestinal paralysis after colon surgery, for prevention
of postoperative ileus (NCT01050712), and for the improve-
ment of tolerability in patients receiving kidney transplants
(NCT00531856).
The use of CO for therapeutic purposes presents two
main advantages: (i) it is an endogenous product and the
organism is fully adapted to and (ii) CO is not metabolized2 Biochemistry Research International
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Figure 1: Two main aspects are involved in CO’s cytoprotective
role targeting mitochondria: modulation of cell metabolism by
improvement of oxidative phosphorylation and inhibition of cell
death by preventing mitochondrial membrane permeabilization.
and reversibly binds to its molecular targets, which makes
the pharmacokinetic much simpler. Due to its therapeutic
potential, large eﬀorts have been initiated in the last years
to develop new ways to deliver this gas to speciﬁc tissues
and organs. The main example is CO-releasing molecules
(CORMs). CORMs are organic and organometallic com-
pounds, able to deliver CO in a timely and tissue-speciﬁc
manner, permitting a signiﬁcant reduction in carboxyhaem-
globin formation and toxicity [7, 9, 10]. In this paper, the
carbon monoxide inﬂuence on cellular and tissue homeosta-
sis by its direct action on mitochondria is emphasised, in
particular on two aspects: cell metabolism and cell death
control (Figure 1).
2. Chemistry of CarbonMonoxide
In biological systems, CO binds almost exclusively to tran-
sition metals, namely, iron, manganese, vanadium, cobalt,
tungsten, copper, nickel, and molybdenum, which are
present in structural and functional proteins [10]. The metal
centre can interact with ligands (usually gases: CO, NO, and
O2) modifying protein activity. The number of molecules
targeted by CO in mammals is very limited; the majority
are haem-containing proteins, whose function is regulated
by the iron of this prosthetic group. Iron is involved in
the regulation of protein function by being part of haem
structure. In contrast to NO, that can bind to Fe3+ and
Fe2+,C Oi so n l ya b l et oa c c e p te l e c t r o n sf r o mF e 2+,w h i c h
promotes a selectivity of CO-targeted haem proteins [10,
11]. Carbon monoxide presents high aﬃnity for binding to
haemoglobin and myoglobin, which competes with oxygen
and compromises its delivery into tissues, causing hypoxia.
Another member of globin superfamily is neuroglobin
(Ngb), which is predominantly expressed in neurons and
confers neuroprotection against hypoxic-ischemic injury
[12]. Although the exact Ngb role is yet to be disclosed,
its possible function includes O2 storage and transport or
detoxiﬁcation of ROS and NO. Furthermore, CO binding to
the haem centre of Ngb leads to conformational changes and
cellular signalling [13].
CO also activates soluble guanylate cyclase (sGC) and
nitric oxide synthase (NOS), but higher levels of CO are
usually required and its physiological role is not yet clariﬁed.
Finally, the last mitochondrial electron transport chain
complex, cytochrome c oxidase appears as another potential
binding target for CO in vivo [14].
Despite the biological functions associated to CO in vivo
and the existence of several proteins capable for binding
CO in vitro; it is still a matter of discussion: the actual
physiological target of CO.
3. CarbonMonoxide and
Cytochrome c Oxidase
Mitochondrion regulates cell metabolism, being the main
energy source, responsible for most of cellular ATP pro-
ductionviaoxidative phosphorylation.Mitochondrial mem-
brane permeabilization is also tightly involved in cell death
modulation and participates in signal transduction cascades,
since several signaling factors are released from mitochon-
drial inter-membrane space. In 1970, it was ﬁrst claimed that
CO’s toxicity could be derived from its targeting and binding
to the mitochondrial haem-protein cytochrome c oxidase
(COX)[15].Cytochromec oxidaseistheﬁnalelectronaccep-
tor of the mitochondrial electron transport chain, catalysing
the oxidation of ferrocytochrome c by gaseous oxygen.
Binding of CO to COX (cytochrome a, a3) was fol-
l o w e di nr a tb r a i nb yr e ﬂ e c t a n c es p e c t r o p h o t o m e t r y .I nr a t
exposed to CO (up to around 70% of carboxyhaemglobin
levels in the blood) cytochrome a, a3 absorption (605nm)
increased in the parietal cortex, but no data on COX
enzymatic activity were revealed [16, 17]. 90 minutes after
ending CO exposure, cytochrome oxidation state improved
to 80% of control under normobaric oxygen exposure and
recovered completely under hyperbaric oxygen exposure
[17]. It is worthy of note that 70% of carboxyhaemglobin
levels is very high and exceeds the limit of toxicity. Usually,
the used CO concentrations for animal experiments (∼250–
500ppm) reach around 10 to 20% of carboxyhaemglobin
levels.
In isolated mitochondria from human muscle, CO par-
tially prevented COX activity at 50, 100, and 500ppm, while
no eﬀect was obtained in respiratory complexes I, II, or III
[18]. In mouse leukaemic monocyte macrophage cell line,
1h of CO exposition (250ppm) decreased COX activity,
which was assessed in permeabilized cells [19]. In contrast,
cytochrome c oxidase presented a two-step response to low
concentrations of CO saturated solutions (10μM) in isolated
mitochondria from mouse liver [20]andfromratbrain[21].
In the ﬁrst minutes (5 to 10) COX activity was partially
prevented, while after 30 minutes its activity increased.
Furthermore, COX-speciﬁc activity also increased whenever
intact astrocytes were treated with 50μMo fC Oa f t e r3o r
24h [21].
These apparent controversial data can be due to diﬀerent
tested CO concentrations, period of gas exposure, and the
time point for assessing cytochrome c oxidase activity. Still,
CO eﬀect on COX activity is also dependent on the systemBiochemistry Research International 3
oxygen concentration. Indeed, CO competes with oxygen for
binding to cytochrome c oxidase. However, the relative CO-
O2 aﬃnity (M∗) is about 220 for haemoglobin and 20–25 for
myoglobin while it is close to unit for cytochrome c oxidase
[22]. Thus, the acute toxicity triggered by exogenous CO
is mostly due to its high aﬃnity for haemoglobin, limiting
tissueoxygenation. Accordingly,CO capacitytobind to COX
is highly dependent on oxygen concentration [14, 23]. Thus,
another factor that might inﬂuence the distinct COX activity
responses to CO found in the literature is the presence of
oxygen concentration.
Accordingly, Fukuda et al. have shown that activation of
hypoxia-inducing factor-1 (HIF-1) was involved in the reg-
ulation of cytochrome c oxidase subunits for optimizing the
eﬃciency of mitochondrial respiration [24] and in macro-
phages CO-activated HIF-1 without increasing the rate of
glycolysis [25]. Thus, one can speculate that CO improves
COX activity by activation of HIF-1.
Finally, unlike NO and H2S that are readily metabolized
by oxidative processes within COX, CO oxidation is too slow
to be physiologically relevant as a substrate for COX [14].
4. CarbonMonoxide and
Mitochondrial Respiration
An indirect way for assessing CO eﬀect on mitochondria and
on COX activity is by following cellular oxygen consump-
tion. Under normoxia (21% of oxygen in gaseous phase),
exogenous CO application or endogenous CO (generated by
overexpression of HO-1 or by lipopolysaccharide induced
HO-1 expression) slightly inhibited cell respiration, but it
is not clear the physiological importance of this inhibition.
In contrast, endogenous or exogenous CO considerably
decreased cellular respiration under hypoxia conditions (1%
of oxygen) [23]. Thus, tissue hypoxia and CO appeared to
have a synergistic eﬀect on COX inhibition. It can be spec-
ulated that CO signiﬁcantly inhibits COX only when tissue
oxygen delivery is already compromised by the presence of
high levels of carboxy-haemoglobin and carboxymyoglobin.
Furthermore, under low O2 concentration the electron
transport chain is in a more reduced state, which is a more
favourable state for CO to bind, since CO has the ability for
binding to reduced iron [10, 26].
In isolated mitochondria from kidney, respiratory con-
trol index was assessed immediately after adding three
diﬀerent CO-releasing molecules (CORM-2, CORM-3, and
CORM-A1) at 10, 50, and 100μM. Oxygen consumption
was measured in the presence (state 3) or absence (state 4)
of ADP; the ratio between state 3 and 4 is the respiratory
control index (RCR) and indicates the tightness of the
coupling between respiration and phosphorylation. At this
earlytimepointCOdecreasedrespiratorycontrolindex[27].
In contrast, during reperfusion, after kidney cold storage,
CO is released by CORM-3 or CORM-A1 increased renal
mitochondrial respiration, improving its function [28].
Iacono et al. have claimed that CO limits excessive
mitochondrial ROS production and avoids oxidative stress
by inducing a mild-uncoupling state [29]. This hypothesis
was based on the following data. First, low concentrations
(up to 20μM) of CORM-3 weaken the coupling between
ATPproductionandrespiration.Intheabsenceofexogenous
ADP (state 4), CO-treated heart-isolated mitochondria pre-
sented an increase on oxygen consumption. In this situation,
complex II appears to be the target of CO since inhibition
of complex II (malonate addition) reverted the CO-induced
augmentation of oxygen consumption. Second, in the pres-
ence of ADP (state 3), 100μM of CORM-3 decreased oxygen
consumption, which was claimed to be due to complex
IV inhibition. Third, CORM-3 at 20 or 100μM decreased
mitochondrial membrane potential (ΔΨm). This decrease
was prevented by the addition of inhibitors for uncoupling
respirationproteins(UCP)andforadeninenucleotidetrans-
porter (ANT), indicating that CO might open UCP and/or
ANT for providing a mild uncoupling state. Taken all
together, CO-induced cytoprotection was correlated with a
mitochondrialmilduncouplingstimulation,whichdecreases
excessive and toxic mitochondrial ROS production [29].
However, all data were obtained using isolated heart mito-
chondria and the actual physiological role remains to be
disclosed. Still, only an early-response of CO was assessed,
thus further studies are necessary to clarify the CO late
response on mitochondrial mild uncoupling.
In a distinct experimental approach, astrocytes isolated
from cortex have received one brief exposition to CO (by
addition of CO-saturated solution at 50μM ﬁnal concentra-
tion from which the gas diﬀuses rapidly) and cell-speciﬁc
oxygen consumption was assessed during 36h. Indeed, brief
exposition to CO increased cellular oxygen consumption in
intact astrocytes, which was justiﬁed by an improvement of
mitochondrial respiratory chain and oxidative metabolism
[21].
Accordinglytothetwo-steptimeresponse ofcytochrome
c oxidase activity to CO; whereas it was observed an early
or late response corresponding to a decrease or an increase
on COX activity, respectively [20, 21]. Lancel et al. have
also found that mitochondrial respiration has two distinct
responses to CO depending on its concentration [30]. In
heart-isolated mitochondria, 0.5 and 1μMo fC O R M - 3
increased respiratory control ratio (RCR) and mitochondrial
transmembranepotential(ΔΨm),whileat5and10μMthere
is a decrease in RCR and ΔΨm[ 30]. Once again, experimen-
tal conditions (concentration or period of exposure) might
change the tight mitochondrial balance and modulation
of oxidative metabolism, namely, the inﬂuence of CO on
COX activity, mitochondrial respiration, or cellular oxygen
consumption.
5. CarbonMonoxide and
Mitochondrial Biogenesis
CO eﬀect on mitochondria is not limited to organelle func-
tioning but also involves modulation of their population.
In fact, mitochondrial biogenesis stimulation appears to
be one of the CO biological functions in several models.4 Biochemistry Research International
In the heart and in isolated cardiomyocytes, CO trig-
gered mitochondrial biogenesis, which was activated by
the expression of nuclear respiratory factor 1 (NRF-1),
binding to mitochondrial transcription factor 3 (TFAM-3)
[31]. CO activation of mitochondrial biogenesis involved
both guanylate cyclase and prosurvival kinase Akt/PKB
a n do c c u r r e di nah y d r o g e n - p e r o x i d e - ( H 2O2-) dependent
manner. Cell transfection with mitochondrial-targeted cata-
lase, which scavenges mitochondrial H2O2, prevented CO-
induced mitochondrial DNA replication [31]. Likewise,
heamoxygenasemodulatescardiacmitochondrialbiogenesis
via gene expression and nuclear translocation of nuclear
factor erythroid-2-related factor 2 (Nrf2), which upregulates
expression of nuclear respiratory factor 1 (NRF-1) [32].
Furthermore, the same authors have shown that CO/haem
oxygenase system prevented murine doxorubicin cardiomy-
opathy by reversing mitochondrial biogenesis inhibition
[33]. In another pathological model, peritonitis-induced
sepsis, carbon monoxide can rescue mice from death by
providing energetic metabolic support via activating mito-
chondrial biogenesis [30]. CORM-3 treatment activated
mitochondrial biogenesis and induced an increase on RCR,
ΔΨm, mitochondrial H2O2 concentration, and mitochon-
drial DNA level. However, none great eﬀect on pro- or anti-
inﬂammatory markers (TNF-α or IL-10) was observed, only
after 48h a slight increase on IL-10 was found [30]. More
recently,inanotherrodentmodelofsepsis,inductionofHO-
1 coupled activation of mitochondrial biogenesis to anti-
inﬂammatory cytokine expression, such as IL-10 or sIL1-
Ra [34]. A boost of CO exposure, using saturated solutions,
alsoactivatedmitochondrialbiogenesisinastrocytesfromrat
cortex [21]. Finally, in human skeletal muscle exposition to
lowconcentrationsofCO(1h/dayat100ppmduring5days)
stimulated mitochondrial biogenesis involving regulation of
the mitochondrial DNA transcriptome [35].
Therefore, activation of mitochondrial biogenesis is
another biological function conferred by carbon monoxide
for the improvement of cell metabolism and for providing
cytoprotection.
6. CarbonMonoxide, Metabolism,
andEnergyStatus
Based on the facts that CO increases mitochondrial popula-
tion, modulates mitochondrial respiration, and can regulate
mitochondrial respiratory complexes, it is not surprising the
great inﬂuence of CO on cellular metabolism and energetic
status.
Carbon monoxide improved cardiac energy in a model
of ischemia and reperfusion in pigs, preventing edema and
apoptosis [36]. Pigs were ventilated for 2h with 250ppm
CO and then subjected to cardiopulmonary bypass. CO
treatment had no eﬀect on ATP/ADP ratio before ischemia,
but after reperfusion CO resulted in higher levels of
ATP. Likewise, phosphocreatine, a high-energy phosphate
reserve in the cell, which facilitates intracellular high-energy
phosphate transport, slightly decreased with CO treatment
before ischemia. Yet, after reperfusion, the phosphocreatine
levels in CO-treated hearts were signiﬁcantly higher than in
nontreated animals. Thus,CO improved energetic statusand
prevented cardiac tissue damage by edema and cell death
[36]. Likewise, in a similar model of heart ischemia in pigs,
CO was administrated at concentrations with the goal to
obtain up to 5% of carboxyhaemglobin in the blood. In CO-
treated animals the lactate production/glucose consumption
ratio decreased, meaning that higher amounts of pyruvate
entered and were metabolized by TCA cycle and a decrease
on glycolytic metabolism was observed [37]. In human hep-
atocytesorprimarycultureofmousehepatocytes,exogenous
or heam-oxygenase-1-derived CO stimulated ATP genera-
tion [38, 39]. In this model, activation of soluble guanylyl
cyclase (sGC) was the proposed pathway for ATP generation
increase, and the strength of p38 MAPK activation was
correlated with the availability of ATP. Furthermore, 1h
of CO inhalation (at low concentrations: 100 to 500ppm)
enhanced sGC activity and ATP generation in mouse liver,
improving the survival in mice death after initiation of
fulminant hepatitis [38]. Finally, in primary culture of
astrocytes, CO treatment also stimulated ATP generation by
improving oxidative metabolism [21].
7. CarbonMonoxide and Cytoprotection
In 2000 Brouard et al. demonstrated for the ﬁrst time the
antiapoptotic property of the system HO-1/CO in endothe-
lial cells, whose mechanism of action was dependent on
the activation of the p38 mitogen-activated protein kinase
(MAPK) signaling transduction pathway [40]. Since then
and in many diﬀerent models of lung, brain, smooth muscle
cells, liver or endothelial cells low concentrations of exoge-
nous CO, or haem oxygenase-derived CO have shown to
confer resistance against cell death [6–8].
In hepatocytes, CO prevented TNF-α-induced apoptosis
via inhibiting caspase-8 [41] or CO prevented oxidative
stress-induced apoptosis by inhibition of p54 JNK isoform
[42]. Likewise, CO-induced hepatocyte NF-kappaB activa-
tion and apoptosis protection presenting reactive oxygen
species (ROSs) generation as signaling molecules [43]. Low
levels of exogenous CO attenuated anoxia-reoxygenation-
induced lung endothelial cell apoptosis via activation of p38
MAPK and STAT 3, which prevented caspase-3 activation
[44, 45]. Additionally, CO protected against hyperoxia-
induced endothelial cell apoptosis by preventing excessive
ROS formation, bid activation, mitochondrial translocation
of Bax, cytochrome c release, and caspase-9/3 activation
[46].Inneuronalprimarycultures,COpreventedglutamate-
induced apoptosis through ROS generation and activation of
sGCandinduciblenitricoxidesynthase(iNOS)[47].Carbon
monoxide blocks apoptosis in vascular smooth muscle cells,
in part, by activating the cGMP signaling pathway [48, 49].
Thus, cytoprotection, namely, prevention of apoptosis,
jointly with anti-inﬂammatory properties, are the two most
explored biological functions of CO.Biochemistry Research International 5
8. Role of Mitochondria and ROS Signallingon
CostimulatedCytoprotection
Despite the existence of a long list of publications demon-
strating cytoprotection of CO, the role of mitochondria on
CO-induced cell death modulation is still poorly explored.
First evidence showing mitochondria involvement on CO
mode of action raised from the crucial role of ROS as
signalling molecules, which were generated at mitochondrial
level. Experimental approaches using respiratory deﬁcient
ρ0 cells revealed the importance of mitochondrial generated
ROS for CO to prevent inﬂammation in macrophages [19,
25] and to inhibit cell death in hepatocytes [43]. Further-
more,antioxidantadditionhasalsoindicatedtheimportance
of ROS signalling in several models, by reversing biological
functions of CO, such as: (i) cardioprotection via inhibition
of L-type Ca2+ channels [50], (ii) inhibition of apoptosis in
astrocytes and neurons [47, 51], (iii) antiproliferative eﬀect
in airway smooth muscle cells [52], and (iv) induction of
mitochondrial biogenesis in cardiomyocytes [31]. Thus, low
levelsofROSappearasimportantsignallingmoleculesinCO
biology. It is worthy of note that although presenting ROS as
essential signalling molecules, CO also limits mitochondrial
oxidativestressandexcessiveROSgeneration,forinstanceby
inducingamilduncouplingeﬀect[29].HowCOcontrolsthe
tight balance between generation of low signalling and high
toxic levels of ROS is still a matter of debate.
SeveralhypothesesexistintheliteratureforthemodeCO
generates signalling ROS. Under physiological conditions,
mitochondria continuously produce low levels of anion
superoxide (O2
−) as a byproduct of oxidative phosphory-
lation since 1–3% of the consumed oxygen is incompletely
reduced to O2
−. Anion superoxide is rapidly converted into
hydrogen peroxide (H2O2) by the superoxide dismutase
present in the mitochondrial matrix (Figure 2(a))[ 53].
Interestingly, hydrogen peroxide is much more stable than
anion superoxide, is capable of diﬀusing through biolog-
ical membranes [54] and is a potent signalling molecule
[55]. A growing body of evidence suggests that ROSs
are physiologically generated at the level of complexes I
and III of the mitochondrial respiratory chain. The most
accepted hypothesis for CO to generate mitochondrial ROS
is supported by CO capacity of (partially and/or reversely)
inhibiting cytochrome c oxidase (complex IV), leading to
electron accumulation at complex III level, which facilitates
anion superoxide generation (Figure 2(b))[ 56]. Still, one
can also speculate that CO induces mitochondrial ROS
generation by accelerating mitochondrial respiration and
oxidative phosphorylation, increasing the amount of oxygen
that is not totally reduced into water (Figure 2(c)). The exact
mitochondrialtargetandmodeofactionforCOtoaccelerate
mitochondrial respiration and functioning is still a matter
of debate: complex IV is the strongest candidate [56], but
complex II also seems to be involved [29]. Furthermore, CO
also stimulates mitochondrial biogenesis, which can cause
augmentation of ROS by increased mitochondrial popula-
tion.
9. Mitochondrial Membrane Permeabilization
andCarbon Monoxide
Apoptosis occurs via two distinct pathways: an extrinsic
pathway (relying on cell surface membrane receptors) and
an intrinsic pathway, which is triggered by several conditions
of intracellular stress, leading to mitochondrial membrane
permeabilization (MMP). In many models, MMP induces
(i) mitochondrial transmembrane potential dissipation, (ii)
respiratory chain uncoupling, (iii) ROS overproduction, (iv)
ATP synthesis arrest, and (v) the release of several death-
regulating molecules (activating proteases and nucleases),
making the cell death process irreversible [57]. Despite the
vastamountofpublicationsconcerningcelldeathprevention
by CO, very few data are available for CO’s direct implication
on MMP control.
In 2006 Piantadosi et al. performed an interesting
study on mitochondrial permeability pore transition, oxida-
tive stress, and carbon monoxide. Rats were continuously
e x p o s e dt o5 0p p mo fC Of o r1 ,3 ,o r7d a y s .A td a y1a n d3 ,
CO has increased a prooxidative state at liver mitochondria,
which were more sensitive to Ca2+ for opening a pore on
mitochondrial membrane. While at day 7, continuously
exposure to CO prevented MMP in liver mitochondria
by increasing expression of antioxidant enzymes: haem
oxygenase-1 (HO-1) and manganese superoxide dismutase
(SOD-2) [58]. Thus, CO-induced preconditioning generates
an anti-oxidant state, which promotes liver resistance against
MMP.
The direct role of CO on targeting mitochondria was
evaluated in isolated nonsynaptic mitochondria from rat
cortex. MMP was induced by Ca2+ and carboxyatracty-
loside treatment followed by the assessment of: (i) loss
of mitochondrial potential, (ii) the opening of a ∼800Da
pore through the inner membrane, (iii) swelling, and (iv)
cytochrome c release [51]. CO inhibition of these four events
was reversed by the addition of an antioxidant, β-carotene,
indicating that ROS are important signalling molecules at
mitochondrial level. Moreover, CO induced slight increase
inmitochondrial-oxidizedglutathione,whichtriggeredANT
glutathionylation and enhanced its ATP/ADP translocation
activity through the inner membrane. Thus, CO directly
prevented MMP and its consequent astrocytic cell death
and accelerated ATP/ADP transport through mitochon-
dria. Accordingly, upregulation of HO-1 (by overexpression
or cobalt protoporphyrin addition) is associated with an
increase on mitochondrial transport carriers (carnitine,
deoxynucleotide, and ATP/ADP carriers) and cytochrome c
oxidase activities in experimental diabetes [59]. In isolated
liver mitochondria from mouse, pretreatment with CO also
inhibited mitochondrial swelling, depolarization, and the
opening of a pore through the inner membrane, in a ROS-
dependent manner [20]. In addition, cytochrome c oxidase
transiently responded to low concentrations of CO by
decreasing its activity in the ﬁrst 5 minutes after treatment,
while later on there was an increase of COX activity detected
up to 30 minutes [20].6 Biochemistry Research International
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Figure 2: Proposed models for CO action on mitochondria. (a) Under physiological conditions, 1–3% of the consumed oxygen is
incompletely reduced to anion superoxide (O2
−), which is rapidly converted into hydrogen peroxide (H2O2) by the superoxide dismutase
present in the mitochondrial matrix. (b) The most accepted hypothesis for CO to generate mitochondrial ROS is based on partially and/or
reversely inhibition of cytochrome c oxidase (complex IV), leading to electron accumulation at complex III level, which facilitates anion
superoxidegeneration.(c)SincelowdosesofCOalsoimprovemitochondrialrespiration,itcanbespeculatedthatCOinducesmitochondrial
ROS generation because oxidative phosphorylation is accelerated. The exact mitochondrial target is not fully understood, but complexes II
and IV are strong candidates.Biochemistry Research International 7
              Activation 
of mitochondrial biogenesis
Modulation of complex IV
O2 consumption
CO
ATP production
Figure 3: CO controls mitochondrial functioning and improves
cellular energetic state (increased ATP generation) by two main
ways: enhance of oxidative phosphorylation and induction of mito-
chondrial biogenesis.
It is worth of note that CO stimulates the antiapoptotic
protein Bcl-2 expression in lung and cerebral ischemia mod-
els [60, 61], and Bcl-2 can translocate into mitochondrial
membranes for preventing their permeabilization and cell
death. Thus, CO is also capable for preventing MMP by
indirectly acting on Bcl-2 expression levels and subcellular
localization.
10. FinalRemarks
“The dose makes the poison”, carbon monoxide, a simple
and small molecule, known to be toxic, presents bene-
ﬁcial pleiotropic eﬀects. Low concentrations of CO are
able to activate distinct endogenous cell defence mecha-
nisms: antiapoptosis, anti-inﬂammation, antiproliferation,
metabolism improvement, cardioprotection, and so forth.
By preconditioning the cells CO is a cytoprotective factor,
and mitochondria appear as the main cellular targets. In
addition, CO is an endogenous gaseoustransmitter, which
is physiologically generated in response to several types of
stress.
Diverse, and apparently controversial, data are available
in the literature concerning CO model of action on mito-
chondria, in particular on cytochrome c oxidase activity
and on oxygen consumption. One can speculate that CO
biological activity might depend on two main factors: period
of CO exposure and gas concentration, giving rise to distinct
responses. Furthermore, diﬀerent CO sources increase the
systemcomplexityanddonotfacilitatedatacomparison.For
instance,COcanbeappliedbydiﬀerentmodes:(i)onesingle
burst of CO (CO-saturated solutions fast gas diﬀusion), (ii)
gas exposition (continuously application during the period
of exposition), and (iii) CO-releasing molecules. Depending
on the used CORM and its speciﬁc molecular characteristics,
these molecules can be slow or fast CO releasers or can
diﬀerently respond to tissues or to a physiological situation,
such as an increase on oxidative stress.
In conclusion, CO controls mitochondrial functioning
andoxidative metabolism, improving cellularenergeticstate,
by modulation: COX activity, oxygen consumption, mito-
chondrial biogenesis, and ROS generation (Figure 3). Addi-
tionally, CO also prevents cell death: (i) by directly target-
ing mitochondria and inhibiting mitochondrial membrane
permeabilization (MMP), (ii) by increasing antiapoptotic
gene expression, such as Bcl-2, which also prevents MMP, or
(iii) by interacting with the apoptosis-inducing cytochrome
c-cardiolipin complex and inhibiting caspase activation
[62].
The future in CO research ﬁeld lays on the disclosure
of the cross-talk between cell death and cell metabolism
modulation (Figure 1). Mitochondria are the key organelle
involved in the control of both cellular events. Thus, search-
ing for the physiological mitochondrial target of CO and
the biochemical and cellular mechanisms involved is crucial
for the development of this gaseoustransmitter as a novel
therapeutic agent.
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